D.E. Shaw & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.3M	Buy	1,965,610 +62,925	+3%	+$1M	0.02%	962
2025 Q4	$30.9M	Buy	1,902,685 +1,164,509	+158%	+$19M	0.02%	976
2025 Q3	$11M	Buy	738,176 +129,896	+21%	+$1.58M	0.01%	1599
2025 Q2	$7.09M	Buy	+608,280	New	+$5.53M	0.01%	1756
2024 Q1	–	Sell	-41,743	Closed	-$205K	–	4299
2023 Q4	$205K	Sell	41,743 -89,526	-68%	-$408K	﹤0.01%	3876
2023 Q3	$715K	Buy	131,269 +43,321	+49%	+$286K	﹤0.01%	3263
2023 Q2	$590K	Sell	87,948 -139,781	-61%	-$1.04M	﹤0.01%	3355
2023 Q1	$2.01M	Buy	227,729 +111,547	+96%	+$983K	﹤0.01%	2695
2022 Q4	$888K	Buy	116,182 +57,498	+98%	+$447K	﹤0.01%	3530
2022 Q3	$418K	Sell	58,684 -97,500	-62%	-$918K	﹤0.01%	4136
2022 Q2	$1.26M	Buy	156,184 +23,981	+18%	+$211K	﹤0.01%	3466
2022 Q1	$1.83M	Buy	+132,203	New	+$2.08M	﹤0.01%	3386
2020 Q3	–	Sell	-19,068	Closed	-$923K	–	3784
2020 Q2	$923K	Buy	+19,068	New	+$695K	﹤0.01%	2994
2020 Q1	–	Sell	-27,456	Closed	-$821K	–	3887
2019 Q4	$821K	Buy	+27,456	New	+$788K	﹤0.01%	3116